Pharmacological Intervention for Refractory Biofilm Infection After Hemipelvic Replacement Surgery: Multidisciplinary Management of a Case of Giant Cell Tumor of Bone
American Journal of Case Reports · 2025
DOI: 10.12659/ajcr.949210 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, 2025. Verfasst von Liling Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Biofilms, Prosthesis-Related Infections, Anti-Bacterial Agents, Giant Cell Tumor of Bone. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
- School of Pharmaceutical Science, Guangxi Medical University, Nanning, Guangxi, China.
- Department of Bone and Soft Tissue Neurosurgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
ORCID-Profile: Linyu Wang
Zitieren
APA
Huang, L., Wang, L., Nong, H., Liu, B., & Li, Y. (2025). Pharmacological Intervention for Refractory Biofilm Infection After Hemipelvic Replacement Surgery: Multidisciplinary Management of a Case of Giant Cell Tumor of Bone. American Journal of Case Reports. https://doi.org/10.12659/ajcr.949210
Vancouver
Huang L, Wang L, Nong H, Liu B, Li Y. Pharmacological Intervention for Refractory Biofilm Infection After Hemipelvic Replacement Surgery: Multidisciplinary Management of a Case of Giant Cell Tumor of Bone. American Journal of Case Reports. 2025. doi:10.12659/ajcr.949210
BibTeX
@article{Huang2025,
author = {Huang, Liling and Wang, Linyu and Nong, Hao and Liu, Bin and Li, Yan},
title = {Pharmacological Intervention for Refractory Biofilm Infection After Hemipelvic Replacement Surgery: Multidisciplinary Management of a Case of Giant Cell Tumor of Bone},
journal = {American Journal of Case Reports},
year = {2025},
doi = {10.12659/ajcr.949210}
}
EUVIMED